Total Payments
$3,586
2024 Payments
$1,490
Companies
17
Transactions
211
Medicare Patients
12,249
Medicare Billing
$719,479
Payment Breakdown by Category
Food & Beverage$3,521 (98.2%)
Education$64.95 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,521 | 210 | 98.2% |
| Education | $64.95 | 1 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $709.27 | 54 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $507.44 | 25 | $0 (2024) |
| ABBVIE INC. | $464.91 | 29 | $0 (2024) |
| Janssen Biotech, Inc. | $389.68 | 26 | $0 (2024) |
| Lilly USA, LLC | $249.46 | 15 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $242.82 | 13 | $0 (2024) |
| Almirall LLC | $203.50 | 10 | $0 (2024) |
| Dermavant Sciences, Inc. | $156.55 | 8 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $139.86 | 8 | $0 (2023) |
| Incyte Corporation | $110.23 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,490 | 90 | E.R. Squibb & Sons, L.L.C. ($271.91) |
| 2023 | $867.37 | 46 | Novartis Pharmaceuticals Corporation ($246.07) |
| 2022 | $703.04 | 39 | Novartis Pharmaceuticals Corporation ($143.00) |
| 2021 | $526.09 | 36 | Novartis Pharmaceuticals Corporation ($184.12) |
All Payment Transactions
211 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.65 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.10 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Immunology | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.75 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | Almirall LLC | Seysara (Drug) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: Dermatology | ||||||
| 11/25/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: DERMATOLOGY | ||||||
| 11/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.10 | General |
| Category: Immunology | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.91 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.13 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.36 | General |
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.01 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.28 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.35 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $17.96 | General |
| 10/30/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.33 | General |
| Category: Immunology | ||||||
| 10/28/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $27.62 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Immunology | ||||||
| 10/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.14 | General |
| Category: Immunology | ||||||
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.13 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.41 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.86 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 3,378 | 6,303 | $727,503 | $171,975 |
| 2022 | 19 | 3,091 | 6,127 | $716,968 | $197,915 |
| 2021 | 17 | 2,903 | 5,360 | $603,651 | $187,067 |
| 2020 | 20 | 2,877 | 5,779 | $579,673 | $162,522 |
Total Patients
12,249
Total Services
23,569
Medicare Billing
$719,479
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 696 | 994 | $129,199 | $32,430 | 25.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 588 | 846 | $127,758 | $26,765 | 20.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 411 | 505 | $101,533 | $23,679 | 23.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 372 | 420 | $94,922 | $22,497 | 23.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 245 | 284 | $72,002 | $17,588 | 24.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 90 | 113 | $42,856 | $10,924 | 25.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 414 | 2,487 | $36,887 | $9,668 | 26.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 132 | 132 | $33,500 | $7,750 | 23.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 167 | 167 | $27,889 | $6,585 | 23.6% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 48 | 48 | $13,551 | $3,479 | 25.7% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 45 | 47 | $14,536 | $3,401 | 23.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 70 | 96 | $11,057 | $2,850 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 28 | $8,240 | $2,070 | 25.1% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 17 | 18 | $3,698 | $957.54 | 25.9% |
| 69100 | Biopsy of ear | Office | 2023 | 18 | 19 | $4,180 | $769.43 | 18.4% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 16 | 21 | $2,730 | $505.97 | 18.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 25 | 78 | $2,964 | $55.43 | 1.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 713 | 1,161 | $211,302 | $59,154 | 28.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 569 | 836 | $112,860 | $26,900 | 23.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 362 | 430 | $87,720 | $24,847 | 28.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 221 | 259 | $66,304 | $19,824 | 29.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 199 | 234 | $52,650 | $15,019 | 28.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 93 | 123 | $41,205 | $12,072 | 29.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 411 | 2,459 | $34,426 | $9,898 | 28.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 153 | 153 | $34,731 | $8,649 | 24.9% |
About Sandy Coleman
Sandy Coleman is a Family healthcare provider based in Jasper, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2014. The National Provider Identifier (NPI) number assigned to this provider is 1447667183.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sandy Coleman has received a total of $3,586 in payments from pharmaceutical and medical device companies, with $1,490 received in 2024. These payments were reported across 211 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($3,521).
As a Medicare-enrolled provider, Coleman has provided services to 12,249 Medicare beneficiaries, totaling 23,569 services with total Medicare billing of $719,479. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Jasper, GA
- Active Since 07/15/2014
- Last Updated 09/27/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1447667183
Products in Payments
- Sotyktu (Drug) $507.44
- SKYRIZI (Biological) $373.54
- COSENTYX (Drug) $319.66
- TREMFYA (Drug) $307.16
- COSENTYX (Biological) $268.38
- TALTZ (Drug) $212.70
- Seysara (Drug) $203.50
- Zoryve (Drug) $158.62
- VTAMA (Drug) $156.55
- OPZELURA (Drug) $110.23
- Otezla (Drug) $100.95
- Winlevi (Drug) $83.45
- REMICADE (Biological) $75.89
- ADBRY (Biological) $75.11
- Cimzia (Drug) $62.28
- LIBTAYO (Biological) $50.95
- EPSOLAY (Drug) $49.52
- RINVOQ (Biological) $47.43
- HUMIRA (Biological) $43.94
- Ilumya (Biological) $38.34
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Jasper
Emily Cummins, Np-C, NP-C
Family — Payments: $23,515
Family $23,515
Caroline Garrett, Np-C, NP-C
Family — Payments: $6,332
Family $6,332
Christina Breitweiser, Fnp-C, FNP-C
Family — Payments: $5,324
Family $5,324
Paula Mccarter-Carlisle, Fnp-C, FNP-C
Family — Payments: $4,972
Family $4,972
Mary Hochkins
Family — Payments: $4,197
Family $4,197
Lottie Davenport, Fnp-C, FNP-C
Family — Payments: $4,154
Family $4,154